Epygenix Therapeutics Announces FDA Acceptance of IND to Initiate a Clinical Trial of EPX-100 to Treat Lennox-Gastaut Syndrome
/PRNewswire/ -- Epygenix Therapeutics, Inc. ("Epygenix"), a clinical stage biopharmaceutical company focused on rare and intractable genetic epilepsy,...
United States Williamk Bowes Jr Hahn Jun Lee Scottc Baraban Alex Yang Scientific Advisory Board At Epygenix Therapeutics Inc
Source: prnewswire.com